This is largely due to the discernable effects of the drugs on the body — including slowed breathing and heart rate. But the National Institute on Drug Abuse categorizes heroin and prescription opioids in a class of their own.
Opioids activate the opioid receptors in the central nervous system, which can cause respiratory depression. However, opioids act primarily as analgesics, or painkillers, and rarely have depressant effects unless taken at high doses or with other drugs that produce sedation, namely the classical CNS depressants, such as benzodiazepines and barbiturates.
The Drug Enforcement Administration classifies heroin as a Schedule I controlled substance in the United States — meaning it has no medical uses and a high potential for abuse and addiction. Conversely, most central nervous system depressants, such as Xanax and Ambien, have been approved by the FDA for medical use and scheduled according to their risk for abuse.
Various types of drugs can trigger depression, a mood disorder characterized by fatigue, hopelessness and suicidal thoughts, but that does not mean that these drugs are depressants. The National Institute on Drug Abuse explains that CNS depressants slow brain activity by increasing the activity of the chemical GABA, gamma-aminobutyric acid.
In addition to blocking pain, opioid receptors are involved in feelings of pleasure and in controlling heart rate, sleeping and breathing. This means that while heroin dulls pain and offers a rapid and intense rush, it may also impair cognitive functioning, increase sedation, and slow certain autonomic functions, such as those that control a person’s respiratory rate. In other words, it acts as a depressant.
After an initial surge of pleasure or euphoria people who use heroin often experience heaviness in their arms and legs clouded mental functioning. Another side effect of heroin use is “going on the nod,” which is a back-and-forth state of consciousness and semi-consciousness.
People who use heroin chronically can experience many adverse reactions affecting the body and the mind. Mental disorders such as depression can occur with long-term heroin use.
Seeking addiction treatment can feel overwhelming. We know the struggle, which is why we're uniquely qualified to help.
Your call is confidential, and there's no pressure to commit to treatment until you're ready. As a voluntary facility, we're here to help you heal -- on your terms. Our sole focus is getting you back to the healthy, sober life you deserve, and we are ready and waiting to answer your questions or concerns 24/7.Speak to an Intake Coordinator now.352.771.2700
About one-fourth of heroin users will eventually become addicted to the drug, according to the National Institute on Drug Abuse. And nearly one-half of people addicted to heroin will also suffer from depression.
When a person begins to use more and more heroin to achieve the same initial transient “high,” the brain quickly adapts to the constant presence of the drug.
If the person decides to stop taking the drug, the brain will fail to produce or trigger the high levels of pleasure or feel-good signals it was once accustomed to with the increased stimulation of the heroin. This can lead to symptoms of depression as the brain struggles to adjust.
Untreated depression can become worse or interfere with recovery efforts as a person detoxes. Research shows that heroin users who also suffer from depression have a greater risk of overdose, relapse and suicide.
Signs of depression include:
- Low mood without reason
- Sleep problems
- Change in appetite
- Weight gain or loss
- Extreme fatigue
- Feelings of worthlessness and guilt
- Trouble concentrating
- Slowed or accelerated movements
- Feelings of Hopelessness
- Lack of enjoyment in usual activities or hobbies
- Repeated thoughts of suicide or death
The important thing to remember is that the mood disorder depression is not the same as the depression of the central nervous system and not all drugs with depressant properties are classified as depressant drugs.
If you’re facing a heroin use disorder or depression, help is available for both. Do not wait to seek treatment because both of these disorders can lead to severe health consequences. With treatment centers across the country The Recovery Village can help you find effective treatment options for your mental health and substance use problems. To learn more about how treatment can help you heal, contact a representative at The Recovery Village today.
Darke, S., et al. (2009, March 31). Patterns of major depression and drug-related problems amongst heroin users across 36 months. U.S. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19215987
European College of Neuropsychopharmacology. (2007, October 15). How does the opioid system control pain, reward and addictive behavior? Science Daily. Retrieved from https://www.sciencedaily.com/releases/2007/10/071014163647.htm
Hasin, D.., et al. (2002, April). Effects of major depression on remission and relapse of substance dependence. U.S. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11926938
Jones, PharmD, C. M., et al. (2015, July 10). Vital Signs: Demographic and Substance Use Trends Among Heroin Users – United States, 2002 – 2013. Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6426a3.htm
Martins, S.S., et al. (2012, June). Moos and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiological Study on Alcohol and Related Conditions. U.S. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21999943
McIntosh, C. and Ritson, B. (2018, January 2). Treating depression complicated by substance misuse. Advances in Psychiatric Treatment: Volume 7, Issue 5. Cambridge University Press. Retrieved from https://www.cambridge.org/core/journals/advances-in-psychiatric-treatment/article/treating-depression-complicated-by-substance-misuse/E88007047F906A1BC51820051F5E2034#ref-27
Merrer, J. L., et al. (2009, October). Reward Processing by Opioid System in the Brain. U.S. National Library of Medicine. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482114/
National Institute on Drug Abuse. (2010, September). Comorbidity: Addiction and Other Mental Illnesses. Research Report Series. National Institutes of Health. U.S. Department of Health and Human Services. Retrieved from https://www.drugabuse.gov/sites/default/files/rrcomorbidity.pdf
National Institute on Drug Abuse. (2018, June). Heroin. Drug Facts. Retrieved from https://www.drugabuse.gov/publications/drugfacts/heroin
Nunes, MD, E. V. and Levin, MD, F. R. (2004, April 21). Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis. Journal of the American Medical Association. Retrieved from https://jamanetwork.com/journals/jama/article-abstract/198569
Scherrer, J.F. et al. (2016, January/February). Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations. Annals of Family Medicine: Volume 14, No. 1 54-62. Retrieved from http://www.annfammed.org/content/14/1/54
Substance Abuse and Mental Health Services Administration. (2013). Opioid Overdose Toolkit: Information for Prescribers. Retrieved from https://www.integration.samhsa.gov/Opioid_Toolkit_Prescribers.pdf
U.S. Food and Drug Administration. (2018, June 14). Opioid Medications. Retrieved from https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm337066.htm
U.S. National Library of Medicine. (2018, May 5). Depression – overview. National Institutes of Health. Retrieved from https://medlineplus.gov/ency/article/003213.htm
U.S. National Library of Medicine. (2018, May 5). Opiate and opioid withdrawal. National Institutes of Health. Retrieved from https://medlineplus.gov/ency/article/000949.htm
U.S. National Library of Medicine. (2017, May 14). Pain medications – narcotics. National Institutes of Health. Retrieved from https://medlineplus.gov/ency/article/007489.htm